- Home
- DYN vs EMAT Comparison
DYN vs EMAT Comparison
Compare DYN & EMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | DYN | EMAT |
|---|---|---|
| Founded | 1984 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 2.6B |
| IPO Year | 2020 | 2021 |
Fundamental Metrics
Financial Performance| Metric | DYN | EMAT |
|---|---|---|
| Price | $18.85 | $2.28 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 17 | 2 |
| Target Price | ★ $34.33 | $8.25 |
| AVG Volume (30 Days) | ★ 2.4M | 720.6K |
| Earning Date | 11-05-2026 | 08-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $1,102.50 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $14.00 | $1.28 |
| 52 Week High | $27.31 | $17.50 |
Technical Indicators
Market Signals| Indicator | DYN | EMAT |
|---|---|---|
| Relative Strength Index (RSI) | 60.97 | 58.62 |
| Support Level | $16.65 | $2.15 |
| Resistance Level | $19.46 | $2.26 |
| Average True Range (ATR) | 0.90 | 0.22 |
| MACD | 0.40 | 0.13 |
| Stochastic Oscillator | 93.76 | 77.77 |
Price Performance
Historical ComparisonAbout DYN Dyne Therapeutics Inc.
Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease being treated, a linker, and an antigen-binding fragment that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.
About EMAT Evolution Metals & Technologies Corp. Common Stock
Evolution Metals & Technologies Corp is a critical materials and technology company. The company is focused on developing a secure, dependable, and self-sustaining U.S.-aligned supply chain for critical minerals and materials (CMM), and rare earth elements (REEs). The company is also engaged in recycling end-of-life materials through urban mining to help strengthen domestic resource independence and long-term supply stability.